GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » Deferred Tax

NeoPharm Co (XKRX:092730) Deferred Tax : ₩5,964 Mil (TTM As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is NeoPharm Co Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

NeoPharm Co's change in deferred tax for the three months ended in Mar. 2024 was ₩1,620 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2024 was ₩5,964 Mil.

NeoPharm Co Deferred Tax Historical Data

The historical data trend for NeoPharm Co's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoPharm Co Deferred Tax Chart

NeoPharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,295.78 4,805.48 6,122.33 6,296.17 6,160.49

NeoPharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,816.45 1,532.64 1,331.69 1,479.72 1,620.43

NeoPharm Co Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩5,964 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeoPharm Co Deferred Tax Related Terms

Thank you for viewing the detailed overview of NeoPharm Co's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

NeoPharm Co (XKRX:092730) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » Deferred Tax
Comparable Companies
XKRX:234920 XKRX:078520 XKRX:226320 XKRX:317240 XKRX:362320 XKRX:024720 XKRX:256940 XKRX:123690 XKRX:950140 XKRX:214420 PG XPAR:OR LSE:ULVR BOM:500696 CL LSE:RKT EL KMB KVUE XTER:BEI
Traded in Other Exchanges
N/A
Address
928 Tamnip-dong, Yuseong-gu, Daejon, KOR, 305-510
Website
http://www.neopharm.co.kr
NeoPharm Co Ltd is a South Korean company operating in the household and personal products. The products of the company include skin care brand, skin barrier special dermo cosmetic brand, hospital functional products, and life moisturizing body professional brand.

NeoPharm Co (XKRX:092730) Headlines

No Headlines